Blackstone reports strong Q3 earnings, driven by record assets under management and robust deal activity across its businesses.
Harvard's class of 2029 sees racial shifts, with declines in Black and Hispanic enrollment and a rise in Asian-American share, linked to the 2023 Supreme Court ban on race-conscious admissions.
Moderna halts development of its experimental CMV vaccine after Phase III trial fails to meet primary endpoint, leaving the field without an approved congenital CMV vaccine.
Blackstone reports strong Q3 earnings, driven by record assets under management and robust deal activity across its businesses.
Harvard's class of 2029 sees racial shifts, with declines in Black and Hispanic enrollment and a rise in Asian-American share, linked to the 2023 Supreme Court ban on race-conscious admissions.
Moderna halts development of its experimental CMV vaccine after Phase III trial fails to meet primary endpoint, leaving the field without an approved congenital CMV vaccine.